This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DaVita Collaborates With Shanghai Hospital To Innovate Kidney Care Delivery In China

DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced a collaboration in the Yangpu District of Shanghai, China, with the aim of improving dialysis patients’ quality of life while controlling or minimizing medical expenses. With the support of the district government and approval of the health bureau, DaVita and Shanghai Yangpu Antu Hospital are establishing a Renal Dialysis Technology Collaboration Base at the 400-bed hospital.

Under the agreement, DaVita will provide consultation services to the public hospital on advanced management processes for its renal outpatient visits and dialysis treatments. Additionally, DaVita and the hospital will upgrade clinic technology, expand the number of dialysis stations, and bring its industry-leading quality of care and resulting clinical outcomes to the hospital.

“In support of Chinese health care reform, DaVita’s objective is to pilot a sustainable, cost-effective and high-quality renal care and dialysis network with Antu Hospital and within the Yangpu District,” said Atul Mathur, president of DaVita’s Asia-Pacific operations. “We anticipate this collaboration will serve as a model for other communities in China.”

The arrangement provides DaVita a platform for research aimed at improving patient health outcomes and maximizing cost effectiveness for the Chinese health care system.

“The end stage renal disease population in China is the ultimate beneficiary of this collaboration,” said Dennis Kogod, DaVita’s chief operating officer. “Not only does it promote health care quality improvement, safety and therapeutic effectiveness, we believe it will minimize medical expenses and lead to overall quality of life improvement for patients.”

Last year DaVita entered China with a joint venture deal with 3sBio Inc., a leading Chinese biotechnology developer of biopharmaceutical products, providing dialysis treatments in northeastern China.

DaVita and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc. All other trademarks are the property of their respective owners.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs